Ultrasound Pulse Elastometry: Assessment of One Year’s Practice in the Hepato-Gastroenterology Department of the Saint Camille Hospital in Ouagadougou
- 1 Department of Gastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
- 2 Department of Gastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
- 3 Department of Gastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
- 4 Department of Gastroenterology, Fada N’Gourma Regional Hospital, Fada N’Gourma, Burkina Faso
- 5 Department of Gastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
- 6 Department of Gastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
- 7 Department of Gastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
- 8 Department of Gastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
- 9 Department of Gastroenterology, Donka National Hospital, Conakry, Guinea
- 10 Department of Medicine, Joseph KI-ZERBO University, Ouagadougou, Burkina Faso
- 11 Department of Gastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
- 12 Department of Gastroenterology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
- 13 Faculty of Health Sciences and Techniques, Gamal Abdel Nasser, University, Conakry, Guinea
- 14 Department of Gastroenterology, Tengandogo University Hospital, Ouagadougou, Burkina Faso
Abstract
Aims: To review one year of ultrasound impulse elastometry in a hospital in Ouagadougou. Patients and Method: This is a retrospective descriptive study of data from one year’s use of impulse ultrasound elastometry. Ultrasound impulse elastometry was performed using the FibroScan ® COMPACT 530. Fibrosis was considered significant when E (hepatic elasticity) ≥ 7.2 kPa (F2 fibrosis). The test was considered valid when the IQR/Median ratio ≤ 30% and there were at least 10 valid measurements. Results: A total of 1911 patients underwent FibroScan ® . There were 1079 men, giving a sex ratio of 1.3. The mean age of the patients was 37.9 ± 12.2 years. The indication for FibroScan ® was hepatitis B virus infection in 89% of cases. The validation criteria for FibroScan ® were met in all patients. The mean value for elasticity was 7.9 kPa and for steatosis 212 dB/m. Fibrosis was non-significant in 75.5% of cases. More than half of our patients (56.7%) didn’t have steatosis, 24.8% had mild steatosis, 12.4% had moderate steatosis and 6.1% had severe steatosis. Conclusion: Ultrasound pulse elastometry plays an important role in monitoring chronic liver disease. It allows non-invasive diagnosis of hepatic fibrosis and steatosis. In our context, however, access to the test is limited by its availability only in large urban centers, and by its cost.
- Sandrin, L., Fourquet, B., Hasquenoph, J., Yon, S., Fournier, C., Mal, F., et al. (2003) Transient Elastography: A New Noninvasive Method for Assessment of Hepatic Fibrosis. Ultrasound in Medicine & Biology , 29, 1705-1713. https://doi.org/10.1016/j.ultrasmedbio.2003.07.001
- Silvain, C. (2015) Le patient cirrhotique, une prise en charge complexe. La Revue de l'Infirmière , 64, 16-18. https://doi.org/10.1016/j.revinf.2014.10.010
- Asselah, T., Ripault, M. and Marcellin, P. (2005) Hépatite chronique B: Qui traiter et comment ? Gastroentérologie Clinique et Biologique , 29, 374-383. https://doi.org/10.1016/s0399-8320(05)80784-5
- European Association for the Study of the Liver (2012) EASL Clinical Practice Guidelines: Management of Chronic Hepatitis B Virus Infection. Journal of Hepatology , 57, 167-185. https://doi.org/10.1016/j.jhep.2012.02.010
- Spahr, L. (2012) Les tests non invasifs de fibrose vont-ils remplacer la biopsie hépatique? Revue Médicale Suisse , 8, 1411-1415. https://doi.org/10.53738/revmed.2012.8.347.1411
- Alzon, A. (2022) FibroScan® GO Now Available in France. Echosens. https://www.echosens.com/fr/fibroscan-go-disponible-en-france/
- Sandrin, L., Fournier, C., Miette, V., Yon, S. and Hasquenoph, J.M. (2006) Fibroscan®: Un outil non invasif de mesure de la dureté du foie par élastométrie. ITBM - RBM , 27, 25-31. https://doi.org/10.1016/j.rbmret.2005.07.006
- Sokpon, M., Amrani, L., Salihoun, M., Acharki, M., Serraj, I., Amrani, N., et al. (2016) Évaluation initiale de la fibrose hépatique par le fibroscan chez les porteurs inactifs de l’AgHbs: À propos d’une étude monocentrique marocaine. Hegel , 3, 265-268. https://doi.org/10.3917/heg.063.0265
- Hatrydt, G.D.K., Gogan, P., Yao-Bathaix, F.M., Mahassadi, A.K. and Koffi, A.A. (2024) Dépistage de la stéatose hépatique par le Fibroscan/CAP chez les sujets noirs Africains porteurs d’une Hépatite Virale B chronique en Côte d’Ivoire. Annales Africaines de Medecine , 17, e5495-e5504. https://doi.org/10.4314/aamed.v17i1.7
- Diallo, M.S., Youssouf, O., Yaogo, A., Diallo, D., Diallo, K., Wann, T.A., et al. (2024) Evaluation of Hepatic Fibrosis and Hepatic Steatosis by Pulse Elastography (FIBROSCAN/CAP) in Asymptomatic Patients about 170 Cases at the Donka CHU National Hospital in Conakry. Open Journal of Gastroenterology , 14, 125-138. https://doi.org/10.4236/ojgas.2024.144014
- INSD (2024) Results of the 5th General Census of Population and Housing. https://www.insd.bf/fr/resultats